5 articles suggested by Wafik El-Deiry
Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget.
Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.
Wafik El-Deiry shared a few must-reads paper on X:
Authors: Snežana Hinić et al.
SREBF1-based metabolic reprogramming in prostate cancer promotes tumor ferroptosis resistance
Authors: Guojiang Wei et al.
A Text Message Intervention to Minimize the Time Burden of Cancer Care
Authors: Erin M. Bange et al.
RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
Authors: Zachary Sethna et al.
Immune Checkpoint Inhibitors in Field Cancerization and Keratinocyte Cancer Prevention
Authors: Charlotte Cox et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023